About this episode
The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time Ones and Tooze publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
